Proposed WHO Classification of Lymphoid neoplasm

Slides:



Advertisements
Similar presentations
The WHO Classification of Hematological Malignancies
Advertisements

Lymphoma Classification
Non-Hodgkin’s Lymphoma
Edoardo Pescarmona Dipartimento di Medicina Sperimentale
Rick Allen.  Leukaemia involves widespread bone marrow involvement and a presence in peripheral blood.  Lymphoma’s arise in discrete tissue masses (commonly.
LYMPHOMAS By DR : Ramy A. Samy.
By: Alexander Pilzer, Blakelee Ross, and Joshua Epley
MANTLE CELL Lymphoma (WITH EMPHASIS ON THE gi TRACT)
Non-Hodgkin’s Lymphoma
By the end of this session you should know:
Lymphoma Dr. Raid Jastania Dec By the end of this session you should be able to: –Discuss the basis of the classification of lymphomas –Know the.
Non-Hodgkin Lymphoma Showing Abnormalities of c-myc Including Dual Translocations Involving c-myc and Bcl-2: A Clinicopathologic Study R Jastania, V Kukreti,
The Chronic Lymphocytic Leukemia (CLL)
LYMPHOMA EYAD ALSAEED , MBBS , FRCPC CONSULTANT RADIATION ONCOLOGY
Lymphoma Presentation and Diagnosis Mark B. Juckett MD Division of Hematology University of Wisconsin June 19, 2003.
DIAGNOSING LYMPHOMA AND THE GMCHMDS
Lymphoproliferative disorders
Lymphomas Clonal disorders of lymphoid cells at various stages of differentiation HODGKIN L. NON-HODGKIN L.  immature cells (precursors)  mature cells.
Lymphoma Nada Mohamed Ahmed , MD, MT (ASCP)i.
LYMPHOMA.
Malignant lymphomas.
Goals Understand the differences between Hodgkin Lymphoma and non-Hodgkin Lymphoma Clinically and biologically Understand the differences between aggressive.
Lymphoma DR: Gehan Mohamed.
Non-Hodgkin’s lymphomas-definition and epidemiology
Lymphoma David Lee MD, FRCPC. Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of.
M. Mahmood Khan, MD Hematology-Oncology 12/5/03
Lymphoma. ALLMMCLLLymphomas Hematopoietic stem cell Neutrophils Eosinophils Basophils Monocytes Platelets Red cells Myeloid progenitor Myeloproliferative.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
Lymphoma & other HIV-related malignancies
Lymphoma : Malignancy of Lymphocytes Lymphocytes B-cells T-cells NK-cells (Natural Killer Cells)
Leukopenia, leukocytosis
LYMPHOID NEOPLASMS.
EYAD F. ALSAEED MD, FRCPC ASSISTANT PROFESSOR, COLLEGE OF MEDICINE,KSU CONSULTANT RADIATION ONCOLOGY, KKUH ACTING HEAD HEMATOLOGY / ONCOLOGY UNIT DEPARTMENT.
L YMPHOMA FOR THE G ENERALIST Lee Berkowitz, MD. G OALS AND O BJECTIVES 1. Understand the importance of pathology and staging in the approach to management.
Treatment of Non- Hodgkin’s Lymphoma. Precursor B cell Lymphoblastic Leukemia Remission induction with combination therapy Consolidation phase: –High.
Bone Marrow Biopsy Focal involvement by small B-cell neoplasm without significant plasmacytic differentiation (CD3-, CD20+, PAX5+, kappa IHC-, lambda IHC-,
T-cell lymphoma A. Precursor T-cell lymphomas
T-cell/histiocyte-rich large B cell lymphoma Monirath Hav, MD, PhD fellow Pathology Department Ghent University Hospital.
© Cancer Research UK 2005 Registered charity number Table One: Numbers and rates of new cases, non-Hodgkin lymphoma, UK, 2006 EnglandWalesScotlandN.IrelandUK.
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
PTLD. PTLD: Post-transplant Lymphoproliferative Disorders.
Hodgkin lymphomas Monirath Hav, MD, PhD fellow Pathology Department Ghent University Hospital Adapted from WHO Classification of Tumours of Haematopoietic.
HODGKIN ’ S LYMPHOMA Introduction Lymphocyte Predominance Classical HL  Nodular Sclerosis  Mixed cellularity  Lymphocyte rich  Lymphocyte depletion.
Data quality of leukaemia experiences in the Netherlands
Lymphoproliferative disorders. Several clinical conditions in which lymphocytes are produced in excessive quantities ( Lymphocytosis) Lymphoma Malignant.
Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.
2010 Hematopoietic and Lymphoid Neoplasms
Non Hodgkin”s Lymphoma -- Histology appearance -- Cell of orgin -- Immunophenotype -- Molecular biology -- Clinical featres -- Prognosis -- Out-come of.
R4 고원진 / 백선경 교수님 JOURNAL OF CLINICAL ONCOLOGY Volume 29, Number 14, May 2011 The Gray Zone Between Burkitt’s Lymphoma And Diffuse Large B-Cell Lymphoma.
ANOTHER LUMP IN THE NECK
HANDOUT 3 RARITIES.
Asymptomatic lymphadenopathy Mediastinal mass Systemic symptoms Fever, Pruritus Other nonspecific symptoms and paraneoplastic syndromes Intra-abdominal.
Cellular origin of lymphoma
by Elaine S. Jaffe, Nancy Lee Harris, Harald Stein, and Peter G
Lymphoma Most present as tumor Involving lymph nodes or other lymphoid organs such as the spleen. But extra nodal presentation may seen. Hodgkin’s Lymphoma.
LYMPHOMAS H.A MWAKYOMA, MD.
Lymphoma David Lee MD, FRCPC.
Survey summary PTCL clinical practice recommendations
Cellular origin of lymphoma
Malignant lymphomas (Non-Hodgkin's lymphomas-NHLs)
CASE OF THE MONTH Dr Narender Tejwani Consultant ( Hematopathologist)
Lymphoma/CLL 101: Know your Subtype
Lymphoproliferative disorders
Lymphoma Most present as tumor Involving lymph nodes or other lymphoid organs such as the spleen. But extra nodal presentation may seen. Hodgkin’s Lymphoma.
MLAB Hematology Keri Brophy-Martinez
Non-Hodgkin’s Lymphoma Thomas Kochuparambil 10/20/10
Focus on lymphomas Cancer Cell
Lymphoma Ali Al Khader, M.D. Faculty of Medicine
LYMPHOPROLIFERATIVE DISORDERS
Presentation transcript:

Proposed WHO Classification of Lymphoid neoplasm B cell neoplasm Precursor B cell neoplasm Precursor B-lymphoblastic leukemia/lymphoma (precursor B-ALL) T cell neoplasm Precursor T-cell and NK-cell neoplasm Precursor T-lymphoblastic lymphoma/leukemia (precursor T-ALL)

Mature (peripheral) B cell neoplasm B-cell chronic lymphocytic leukemia/SLL Lymphoplasmacytic lymphoma Splenic marginal zone B-cell lymphoma Hairy cell leukemia Plasma cell myeloma/plasmacytoma Extra-nodal marginal zone B cell lymphoma of MALT type Nodal marginal zone B cell lymphoma Follicular lymphoma Mantle cell lymphoma

Mature (peripheral) B cell neoplasm (cont’d) Diffuse large B cell lymphoma Mediastinal B cell lymphoma Primary effusion lymphoma Burkitt lymphoma/Burkitt cell leukemia

Mature (peripheral) T cell neoplasm T-cell prolymphocytic leukemia T-cell granular lymphocytic leukemia Aggressive NK-cell leukemia Adult T-cell leukemia/lymphoma (HTLV1) Extranodal NK/T cell lymphoma, nasal type Enteropathy type T cell lymphoma Hepatosplenic gamma delta T cell lymphoma Subcutaneous panniculitis-like T cell lymphoma Mycosis fungoides/Sezary syndrome

Mature (peripheral) T cell neoplasm (cont’d) Anaplastic large cell lymphoma, T/null cell, primary cutaneous Peripheral T cell lymphoma, NOS Angioimmunoblastic T cell lymphoma Anaplastic large cell lymphoma, T/null cell, primary systemic

Hodgkin's lymphoma (Hodgkin's disease) Nodular lymphocyte predominant Hodgkin's lymphoma Classical Hodgkin's lymphoma Nodular sclerosis Hodgkin's lymphoma (grades 1 and 2) Lymphocyte-rich classical Hodgkin's lymphoma Mixed cellularity Hodgkin's lymphoma Lymphocyte depletion Hodgkin's lymphoma

Pediatric Follicular Lymphoma Rare lymphoma subtype in children (1-2%) 60% present in head and neck Tonsils, nasopharynx Other sites: lymph nodes, GI tract, testis Many differences with FL in adults Usually Grade II-III Bcl-2 usually negative (both protein & bcl-2R) Male: Female ratio 3:1 85% present with Stage I or II disease 75% CR with low relapse rate

LBCL BL Children LBCL BL Adults

Burkitt-like lymphoma should exist? Burkitt-like lymphoma should be included in: Diffuse large B cell lymphoma or Morphologic variant of Burkitt lymphoma

Burkitt and Burkitt-like Lymphomas May show follicular colonization Cytologically tumor cells resemble the small blasts of the dark zone of the GC High rate of somatic mutations of Ig VH BCL-6+, CD 10+ Evidence favors a germinal center derivation

Burkitt-like Lymphomas Similar to BL, but with greater variation in nuclear morphology MIB-1 100%, CD10 +, bcl-2 - Cytogenetics or molecular genetics desirable for diagnosis - should have a c-myc translocation This morphologic variant more common in immunodeficiency states

In the WHO classification The term “Burkitt-like lymphoma” is retained Burkitt-like lymphoma will be considered a variant of Burkitt lymphoma Intermediate morphology C-myc translocations High proliferative fraction Major criteria:

BURKITT LYMPHOMA Morphologic Variants Classical Burkitt lymphoma Atypical Burkitt/ Burkitt- like With plasmacytoid differentiation (HIV -associated) Subtypes, clinical genetic Endemic Sporadic Immunodeficiency-associated

Anaplastic Large Cell Lymphoma Paradigm for process used to define disease entities (REAL) First recognized based on Morphology - sinusoidal growth Antigenic phenotype - CD30+ Studies of molecular pathogenesis led to new diagnostic tools RT-PCR and ALK-1 monoclonal antibody New diagnostic tools define the borderlands of the disease

Anaplastic Large Cell Lymphoma Clinical Features Presents most commonly in lymph nodes Cutaneous involvement variable Most common in children, young adults Frequent presence of systemic symptoms “B” symptoms or high IPI less often predict poor outcome (in contrast to most other NHL) Aggressive natural history but good response to chemotherapy

DISTRIBUTION OF ANAPLASTIC LARGE CELL LYMPHOMA BY AGE (267 cases) Sex Ratio= 1.34 Number of cases Age

Survival of 154 patients with ALCL 100 ALK+ (n=132) Survival 75 ALK - (n=22) p<0.001 50 25 60 120 180 240 Months

Clinical Significance of ALK + in Anaplastic Large Cell Lymphoma ALK+ cases are seen in younger age groups Children and young adults; M>>F ALK+ cases have better prognostic than ALK-, irrespective of other clinical features; i.e. age, stage or IPI Conclusion: ALK+ ALCL is probably a distinct disease entity, separate from ALK- ALCL